Cue Biopharma (CUE) Accumulated Expenses (2017 - 2026)
Cue Biopharma (CUE) recorded Accumulated Expenses of $14.88 million in Q2 2026, up 880.4% from $1.52 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma reported Accumulated Expenses of $1.61 million, down 44.6% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of -10.4% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $2.91 million in FY2024 (-29.7%), $4.14 million in FY2023 (+16.4%), $3.55 million in FY2022 (-23.1%) and $4.62 million in FY2021 (+65.8%).
- The Q2 2026 figure is the highest quarterly Accumulated Expenses in data going back to Q4 2017.
- On a year-over-year basis, Accumulated Expenses rose in 1 of the last seven quarters, with growth averaging 91.6%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 880.4% in Q2 2026, against a decline of 66.7% in Q2 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Cue Biopharma | 98.78 Mn | 8.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.88 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | 4.14 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 4.08 Mn |
| Mar 31, 2023 | 2.84 Mn |
| Dec 31, 2022 | 3.55 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 3.56 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 4.62 Mn |
| Sep 30, 2021 | 3.99 Mn |
| Jun 30, 2021 | 2.00 Mn |
API Access
Cue Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();